Robin Imperial
Overview
Explore the profile of Robin Imperial including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolf E, Imperial R, Jiang L, Agarwal A, Tun H
J Blood Med
. 2024 Jul;
15:291-303.
PMID: 38947230
Primary cranial neurolymphomatosis (PCNL) is a rare subtype of primary CNS lymphoma (PCNSL) in which infiltrative lymphomatous involvement is confined to cranial nerves. Here, we report a case of PCNL...
2.
Mosalem O, Coston T, Imperial R, Mauer E, Thompson C, Yilma B, et al.
Oncologist
. 2024 May;
29(9):e1224-e1227.
PMID: 38776551
Introduction: Pathogenic mutations in POLE/POLD1 lead to decreased fidelity of DNA replication, resulting in a high tumor mutational burden (TMB-H), defined as TMB ≥ 10 mut/Mb, independent of deficient mismatch...
3.
Imperial R, Mosalem O, Majeed U, Tran N, Borad M, Babiker H
Clin Exp Gastroenterol
. 2024 Apr;
17:121-134.
PMID: 38650920
Despite improvements in overall cancer mortality, deaths related to pancreatic cancer continue to rise. Following first-line treatment, second-line options are significantly limited. Classically, first-line treatment consisted of either gemcitabine or...
4.
Lim M, Franses J, Imperial R, Majeed U, Tsai J, Hsiehchen D
Gastroenterology
. 2023 Jan;
164(6):1006-1008.e3.
PMID: 36708791
No abstract available.
5.
Franses J, Lim M, Burgoyne A, Mody K, Lennerz J, Chang J, et al.
Oncologist
. 2022 Sep;
27(11):e908-e911.
PMID: 36103364
Advanced hepatocellular carcinoma (HCC) is responsive to immune checkpoint inhibitors, but there are currently no known biomarkers to predict treatment benefit. Blood TMB (bTMB) estimation via circulating tumor DNA (ctDNA)...
6.
Imperial R, Nazer M, Ahmed Z, Kam A, Pluard T, Bahaj W, et al.
Cancers (Basel)
. 2019 Sep;
11(9).
PMID: 31546879
Tumor heterogeneity, especially intratumoral heterogeneity, is a primary reason for treatment failure. A single biopsy may not reflect the complete genomic architecture of the tumor needed to make therapeutic decisions....
7.
Imperial R, Ahmed Z, Toor O, Erdogan C, Khaliq A, Case P, et al.
Mol Cancer
. 2018 Dec;
17(1):177.
PMID: 30577807
Right-sided colon cancer (RCC) has worse prognosis compared to left-sided colon cancer (LCC) and rectal cancer. The reason for this difference in outcomes is not well understood. We performed comparative...
8.
Imperial R, Toor O, Hussain A, Subramanian J, Masood A
Semin Cancer Biol
. 2017 Nov;
54:14-28.
PMID: 29175106
Recent advances in Next Generation Sequencing (NGS) have provided remarkable insights into the genomic characteristics of human cancers that have spurred a revolution in the field of oncology. The mitogen-activated...
9.
Gordon B, Imperial R, Wang L, Navarre W, Liu J
J Bacteriol
. 2008 Sep;
190(21):7052-9.
PMID: 18776007
Lsr2 is a small, basic protein present in Mycobacterium and related actinomycetes. Our previous in vitro biochemical studies showed that Lsr2 is a DNA-bridging protein, a property shared by H-NS-like...